Literature DB >> 23526644

Inhibition of Ebola Virus Infection: Identification of Niemann-Pick C1 as the Target by Optimization of a Chemical Probe.

Kyungae Lee1, Tao Ren, Marceline Côté, Berahman Gholamreza, John Misasi, Anna Bruchez, James Cunningham.   

Abstract

A high throughput screen identified adamantane n class="Chemical">dipeptide 1 as an inhibitor of Ebola virus (EboV) infection. Hit-to-lead optimization to determine the structure-activity relationship (SAR) identified the more potent EboV inhibitor 2 and a photoaffinity labeling agent 3. These anti-viral compounds were employed to identify the target as Niemann-Pick C1 (NPC1), a host protein that binds the EboV glycoprotein and is essential for infection. These studies establish NPC1 as a promising target for anti-viral therapy.

Entities:  

Keywords:  Ebola virus; Niemann-Pick C1; photoaffinity label; small molecule inhibitor; target identification; viral entry

Year:  2012        PMID: 23526644      PMCID: PMC3601783          DOI: 10.1021/ml300370k

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  12 in total

Review 1.  Exotic emerging viral diseases: progress and challenges.

Authors:  Thomas W Geisbert; Peter B Jahrling
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

2.  Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.

Authors:  Kathryn Schornberg; Shutoku Matsuyama; Kirsten Kabsch; Sue Delos; Amy Bouton; Judith White
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 3.  Ebola virus pathogenesis: implications for vaccines and therapies.

Authors:  Nancy Sullivan; Zhi-Yong Yang; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

5.  T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus.

Authors:  Andrew S Kondratowicz; Nicholas J Lennemann; Patrick L Sinn; Robert A Davey; Catherine L Hunt; Sven Moller-Tank; David K Meyerholz; Paul Rennert; Robert F Mullins; Melinda Brindley; Lindsay M Sandersfeld; Kathrina Quinn; Melodie Weller; Paul B McCray; John Chiorini; Wendy Maury
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

6.  Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Authors:  Asuka Nanbo; Masaki Imai; Shinji Watanabe; Takeshi Noda; Kei Takahashi; Gabriele Neumann; Peter Halfmann; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

7.  Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.

Authors:  Rama Kondru; Jun Zhang; Changhua Ji; Tara Mirzadegan; David Rotstein; Surya Sankuratri; Marianna Dioszegi
Journal:  Mol Pharmacol       Date:  2007-12-20       Impact factor: 4.436

8.  Catalytic "active-metal" template synthesis of [2]rotaxanes, [3]rotaxanes, and molecular shuttles, and some observations on the mechanism of the cu(i)-catalyzed azide-alkyne 1,3-cycloaddition.

Authors:  Vincent Aucagne; José Berna; James D Crowley; Stephen M Goldup; Kevin D Hänni; David A Leigh; Paul J Lusby; Vicki E Ronaldson; Alexandra M Z Slawin; Aurélien Viterisi; D Barney Walker
Journal:  J Am Chem Soc       Date:  2007-09-11       Impact factor: 15.419

9.  Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes.

Authors:  Mohammad F Saeed; Andrey A Kolokoltsov; Thomas Albrecht; Robert A Davey
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

10.  Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.

Authors:  Marceline Côté; John Misasi; Tao Ren; Anna Bruchez; Kyungae Lee; Claire Marie Filone; Lisa Hensley; Qi Li; Daniel Ory; Kartik Chandran; James Cunningham
Journal:  Nature       Date:  2011-08-24       Impact factor: 49.962

View more
  13 in total

Review 1.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

2.  Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.

Authors:  Melinda Ng; Esther Ndungo; Rohit K Jangra; Yingyun Cai; Elena Postnikova; Sheli R Radoshitzky; John M Dye; Eva Ramírez de Arellano; Ana Negredo; Gustavo Palacios; Jens H Kuhn; Kartik Chandran
Journal:  Virology       Date:  2014-10-11       Impact factor: 3.616

3.  Biochemical Basis for Increased Activity of Ebola Glycoprotein in the 2013-16 Epidemic.

Authors:  May K Wang; Sun-Young Lim; Soo Mi Lee; James M Cunningham
Journal:  Cell Host Microbe       Date:  2017-02-23       Impact factor: 21.023

Review 4.  Hunting Viral Receptors Using Haploid Cells.

Authors:  Sirika Pillay; Jan E Carette
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

5.  Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection.

Authors:  Xiangguo Qiu; Andrea Kroeker; Shihua He; Robert Kozak; Jonathan Audet; Majambu Mbikay; Michel Chrétien
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

6.  Ebola virus mediated infectivity is restricted in canine and feline cells.

Authors:  Ziying Han; Stephen M Bart; Gordon Ruthel; Nathan H Vande Burgt; Kathleen M Haines; Susan W Volk; Charles H Vite; Bruce D Freedman; Paul Bates; Ronald N Harty
Journal:  Vet Microbiol       Date:  2015-11-17       Impact factor: 3.246

7.  Chemical and Structural Aspects of Ebola Virus Entry Inhibitors.

Authors:  Elisabeth K Nyakatura; Julia C Frei; Jonathan R Lai
Journal:  ACS Infect Dis       Date:  2014-12-18       Impact factor: 5.084

8.  Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R.

Authors:  Harilaos Filippakis; Nicola Alesi; Barbara Ogorek; Julie Nijmeh; Damir Khabibullin; Catherine Gutierrez; Alexander J Valvezan; James Cunningham; Carmen Priolo; Elizabeth P Henske
Journal:  Oncotarget       Date:  2017-06-13

9.  Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1.

Authors:  May Kwang-Mei Wang; Tao Ren; Hu Liu; Sun-Young Lim; Kyungae Lee; Anna Honko; Huanying Zhou; Julie Dyall; Lisa Hensley; Ashley K Gartin; James M Cunningham
Journal:  PLoS Pathog       Date:  2018-09-28       Impact factor: 6.823

10.  Ebola virus entry into host cells: identifying therapeutic strategies.

Authors:  Bethany A Rhein; Wendy J Maury
Journal:  Curr Clin Microbiol Rep       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.